Novartis Institutes For Biomedical Research GmbH

Novartis Institutes For Biomedical Research GmbH, headquartered in Austria (AT), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the organisation is part of the Novartis AG corporate family, which has established various climate commitments and initiatives.

As a current subsidiary of Novartis AG, Novartis Institutes For Biomedical Research GmbH inherits its climate strategies and targets. Novartis AG has committed to significant sustainability goals, including initiatives under the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, which focuses on transitioning to 100% renewable energy. These commitments reflect a broader industry trend towards reducing greenhouse gas emissions and enhancing environmental responsibility.

While specific reduction targets for Novartis Institutes For Biomedical Research GmbH are not detailed, the overarching goals set by Novartis AG indicate a strong commitment to addressing climate change and reducing carbon footprints across its operations. The absence of direct emissions data highlights the need for ongoing transparency and accountability in corporate climate strategies.